Terms: = Ovarian cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
15 results:
1. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in ovarian cancer.
Pi Y; Sun F; Zhang Z; Liu X; Lou G
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
[No Abstract] [Full Text] [Related]
3. Nuclear receptor co-repressor ncor2 and its relation to GPER with prognostic impact in ovarian cancer.
Reichenbach J; Fraungruber P; Mayr D; Buschmann C; Kraus FBT; Topalov NE; Chelariu-Raicu A; Kolben T; Burges A; Mahner S; Kessler M; Jeschke U; Czogalla B; Trillsch F
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8719-8728. PubMed ID: 37131060
[TBL] [Abstract] [Full Text] [Related]
4. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.
Taylor JA; Burnell M; Ryan A; Karpinskyj C; Kalsi JK; Taylor H; Apostolidou S; Sharma A; Manchanda R; Woolas R; Campbell S; Parmar M; Singh N; Jacobs IJ; Menon U; Gentry-Maharaj A
BJOG; 2022 Jan; 129(1):110-118. PubMed ID: 34555263
[TBL] [Abstract] [Full Text] [Related]
5. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.
Fekete JT; Ősz Á; Pete I; Nagy GR; Vereczkey I; Győrffy B
Gynecol Oncol; 2020 Mar; 156(3):654-661. PubMed ID: 31973910
[TBL] [Abstract] [Full Text] [Related]
6. The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma.
Xu H; Duan N; Wang Y; Sun N; Ge S; Li H; Jing X; Liang K; Zhang X; Liu L; Xue C; Zhang C
Pathology; 2020 Feb; 52(2):206-212. PubMed ID: 31883669
[TBL] [Abstract] [Full Text] [Related]
7. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial ovarian cancer.
Ma M; Yu N
Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
[TBL] [Abstract] [Full Text] [Related]
8. Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.
Lin HY; Su YF; Hsieh MT; Lin S; Meng R; London D; Lin C; Tang HY; Hwang J; Davis FB; Mousa SA; Davis PJ
FASEB J; 2013 Aug; 27(8):3209-16. PubMed ID: 23640055
[TBL] [Abstract] [Full Text] [Related]
9. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.
Langer W; Sohler F; Leder G; Beckmann G; Seidel H; Gröne J; Hummel M; Sommer A
BMC Genomics; 2010 Nov; 11():676. PubMed ID: 21118496
[TBL] [Abstract] [Full Text] [Related]
10. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
[TBL] [Abstract] [Full Text] [Related]
11. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
Hussein-Fikret S; Fuller PJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
[TBL] [Abstract] [Full Text] [Related]
12. Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.
Kelley KM; Rowan BG; Ratnam M
Cancer Res; 2003 Jun; 63(11):2820-8. PubMed ID: 12782587
[TBL] [Abstract] [Full Text] [Related]
13. Repressors of androgen and progesterone receptor action.
Agoulnik IU; Krause WC; Bingman WE; Rahman HT; Amrikachi M; Ayala GE; Weigel NL
J Biol Chem; 2003 Aug; 278(33):31136-48. PubMed ID: 12771131
[TBL] [Abstract] [Full Text] [Related]
14. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract] [Full Text] [Related]
15. Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway.
Rey JM; Pujol P; Callier P; Cavailles V; Freiss G; Maudelonde T; Brouillet JP
J Mol Endocrinol; 2000 Jun; 24(3):433-40. PubMed ID: 10828836
[TBL] [Abstract] [Full Text] [Related]
